Transcriptional and epigenetic consequences of DMSO treatment on HepaRG cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cells Année : 2022

Transcriptional and epigenetic consequences of DMSO treatment on HepaRG cells

Résumé

Dimethyl sulfoxide (DMSO) is used to sustain or favor hepatocyte differentiation in vitro. Thus, DMSO is used in the differentiation protocol of the HepaRG cells that present the closest drug-metabolizing enzyme activities to primary human hepatocytes in culture. The aim of our study is to clarify its influence on liver-specific gene expression. For that purpose, we performed a large-scale analysis (gene expression and histone modification) to determine the global role of DMSO exposure during the differentiation process of the HepaRG cells. The addition of DMSO drives the upregulation of genes mainly regulated by PXR and PPAR alpha whereas genes not affected by this addition are regulated by HNF1 alpha, HNF4 alpha, and PPAR alpha. DMSO-differentiated-HepaRG cells show a differential expression for genes regulated by histone acetylation, while differentiated-HepaRG cells without DMSO show gene signatures associated with histone deacetylases. In addition, we observed an interplay between cytoskeleton organization and EMC remodeling with hepatocyte maturation.
Fichier principal
Vignette du fichier
cells-11-02298.pdf (3.96 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03774880 , version 1 (12-09-2022)

Licence

Paternité

Identifiants

Citer

Hélène Dubois-Pot-Schneider, Caroline Aninat, Kathrin Kattler, Karim Fekir, Kathleen Jarnouen, et al.. Transcriptional and epigenetic consequences of DMSO treatment on HepaRG cells. Cells, 2022, 11 (15), pp.2298. ⟨10.3390/cells11152298⟩. ⟨hal-03774880⟩
103 Consultations
112 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More